Back
Viper Energy 10K Form
Buy
62
VNOM
Viper Energy
Last Price:
55.40
Seasonality Move:
12.72%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-08 | 10Q | VNOM/Viper Energy Quarterly |
2023-08-03 | 10Q | VNOM/Viper Energy Quarterly |
2023-05-03 | 10Q | VNOM/Viper Energy Quarterly |
2022-11-08 | 10Q | VNOM/Viper Energy Quarterly |
2022-08-03 | 10Q | VNOM/Viper Energy Quarterly |
2022-05-05 | 10Q | VNOM/Viper Energy Quarterly |
Receive VNOM News And Ratings
See the #1 stock for the next 7 days that we like better than VNOM
VNOM Financial Statistics
Sales & Book Value
Annual Sales: | $826.79M |
---|---|
Cash Flow: | $-38.9M |
Price / Cash Flow: | 0 |
Annual Sales: | $13.61 |
Price / Book: | 3.87 |
Profitability
EPS (TTM): | 2.33000 |
---|---|
Net Income (TTM): | $206.15M |
Gross Margin: | $630.27M |
Return on Equity: | 7.18% |
Return on Assets: | 5.36% |
Viper Energy Earnings Forecast
Key Viper Energy Financial Ratios
- The Gross Profit Margin over the past 11 years for VNOM is 76.23%.
- The Selling, General & Administrative Expenses for VNOM have been equal to 1.28% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 24.44% of Operating Income.
- The Net Earning history of VNOM is 24.20% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 6 years.
Viper Energy Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Oil, Gas & Consumable Fuels |
Sector: | Energy |
Current Symbol: | VNOM |
CUSIP: | 92763M |
Website: | viperenergy.com |
Debt
Debt-to-Equity Ratio: | 0.59 |
---|---|
Current Ratio: | 7.24 |
Quick Ratio: | 7.09 |
Price-to-Earnings
Trailing P/E Ratio: | 19.57 |
---|---|
Forward P/E Ratio: | 25.04 |
VNOM Technical Analysis vs Fundamental Analysis
Buy
62
Viper Energy (VNOM)
is a Buy
Is Viper Energy a Buy or a Sell?
-
Viper Energy stock is rated a Buy
The current Viper Energy [VNOM] share price is $52.63. The Score for VNOM is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.